Scully William P: insider trades.
Scully William P reported 10 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 7 open-market purchases ($4.2M) and 0 sales, across 1 company.
- Transactions
- 10
- Purchases (P)
- 7
- Sales (S)
- 0
- Companies
- 1
- Name as filed
- SCULLY WILLIAM P
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Prothena Corp Public Ltd Co (PRTA) | TenPercentOwner | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-29 | Prothena Corp Public Ltd Co | P | 162,000 | $8.68 | 214,000 | Form 4 |
| 2026-09-28 | Prothena Corp Public Ltd Co | P | 103,500 | $8.6 | 187,000 | Form 4 |
| 2026-09-18 | Prothena Corp Public Ltd Co | P | 100,000 | $8.43 | 927,000 | Form 4 |
| 2026-09-02 | Prothena Corp Public Ltd Co | P | 27,000 | $9.47 | 827,000 | Form 4 |
| 2026-08-20 | Prothena Corp Public Ltd Co | P | 50,000 | $8.79 | 800,000 | Form 4 |
| 2026-08-18 | Prothena Corp Public Ltd Co | G | 627,553 | $0 | 750,000 | Form 4 |
| 2026-08-17 | Prothena Corp Public Ltd Co | G | 336,000 | $0 | 1,377,553 | Form 4 |
| 2026-08-10 | Prothena Corp Public Ltd Co | G | 251,553 | $0 | 1,041,553 | Form 4 |
| 2026-08-07 | Prothena Corp Public Ltd Co | P | 3,500 | $8.62 | 83,500 | Form 4 |
| 2026-08-07 | Prothena Corp Public Ltd Co | P | 34,000 | $8.62 | 790,000 | Form 4 |
Questions
What stock did Scully William P buy or sell?
Scully William P reported 10 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 7 open-market purchases ($4.2M) and 0 sales, across 1 company.
Is Scully William P the same person as other filers with this name?
This page covers SEC CIK 1045463 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/scully-william-p-1045463.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.